The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.

According to CDER Director Patrizia Cavazzoni, CDER’s new Center for Real-World Evidence Innovation represents a major step ...

It’s the second time in less than a month that retailer has recalled the medication; this time due to a potential foreign ...

It will be co-led by Patrizia Cavazzoni, director of the FDA's Centre for Drugs Evaluation and Research (CDER), and Centre for Biologics Evaluation and Research (CBER) director Peter Marks.

The approval of Aduhelm based on clearance of amyloid plaques in the brain as a surrogate marker – with an "expectation of clinical benefit" according to Patrizia Cavazzoni, director of the FDA ...

Endpoints Weekly reports on iECURE's gene therapy success for OTC deficiency, FDA CDER director Patrizia Cavazzoni's departure, and Verdiva Bio's $411M launch with Sciwind assets.

Hamza Ziyadne, 23, was abducted in the 2023 Hamas-led attack on Israel alongside his siblings and father, whose body was also recovered this week. By Aaron Boxerman President Nicolás Maduro was ...

Israel and its allies have escalated strikes against the Houthis, trying to force the Iran-backed group to stop firing on Israel and Red Sea shipping. By Aaron Boxerman and Ismaeel Naar The ...